Bio-Rad Laboratories, Hercules, Calif, has launched recombinant ?-2 microglobulin, a critical raw material. The recombinant ?-2 microglobulin is part of the company’s tumor marker product line, engineered for a wide range of diagnostic uses.
The ?-2 microglobulin is a prognostic tumor marker that is found on the surface of many cells. It is also found in the serum in a free form. In multiple myeloma patients, decreasing levels of ?-2 microglubulin can indicate that a treatment is working, while static or increasing levels can indicate that the patient is not responding to treatment.
Bio-Rad’s critical raw materials are cell culture derived antigens and antibodies from human and recombinant cell lines for use in diagnostic controls and calibrators. The products are non-infectious and eliminate the unpredictability associated with native and animal-sourced materials
“Bio-Rad continues its commitment to develop recombinant raw material products that fulfill our customers’ need for a consistent and secure supply independent of human source collections,” says Conrad Maurais, product manager in Bio-Rad’s quality systems division. “This protein enhances our established line of tumor markers, extending our ability to add value and reliability to our IVD customers.”
To learn more, visit Bio-Rad Laboratories.
Featured image: Bio-Rad’s recombinant ?-2 microglobulin is a critical raw material engineered for a wide range of diagnostic uses.
